Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $174.40 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $31.15 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $26.12 | 2 | $0 (2021) |
| Ultragenyx Pharmaceutical Inc. | $22.70 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $21.69 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.10 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $19.43 | 1 | $0 (2021) |
| Lantheus Medical Imaging, Inc. | $18.23 | 1 | $0 (2021) |
| ABBVIE INC. | $13.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.98 | 1 | ABBVIE INC. ($13.98) |
| 2021 | $160.42 | 9 | Amgen Inc. ($31.15) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Gastroenterology | ||||||
| 09/04/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $22.70 | General |
| 08/09/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Gastroenterology | ||||||
| 07/27/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Bone Health | ||||||
| 07/21/2021 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CONTRAST AGENT | ||||||
| 07/13/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Inflammation | ||||||
| 02/18/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: DIABETES | ||||||
| 01/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 754 | 1,499 | $95,800 | $24,490 |
| 2022 | 13 | 539 | 1,117 | $57,913 | $16,961 |
| 2021 | 11 | 526 | 1,136 | $54,995 | $17,952 |
| 2020 | 16 | 719 | 1,376 | $65,157 | $18,797 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 112 | $26,302 | $7,308 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 168 | $27,692 | $7,097 | 25.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 95 | 212 | $7,929 | $3,382 | 42.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 73 | 79 | $9,875 | $2,671 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,091 | $1,147 | 22.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,954 | $994.84 | 33.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 94 | 118 | $5,310 | $730.96 | 13.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 38 | 41 | $1,533 | $664.20 | 43.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 20 | 20 | $1,140 | $220.78 | 19.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 46 | 49 | $1,176 | $152.39 | 13.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 33 | 136 | $4,216 | $44.14 | 1.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 56 | $728.00 | $37.30 | 5.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 53 | 436 | $1,308 | $29.74 | 2.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 15 | 42 | $546.00 | $11.12 | 2.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 152 | 178 | $27,522 | $8,833 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $5,115 | $1,896 | 37.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 59 | 113 | $4,226 | $1,842 | 43.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 46 | 46 | $5,750 | $1,602 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,933 | $1,207 | 30.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 70 | 95 | $4,275 | $670.40 | 15.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 26 | 27 | $1,010 | $422.02 | 41.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 19 | $1,083 | $262.61 | 24.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 29 | 30 | $720.00 | $93.78 | 13.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 18 | 19 | $171.00 | $55.68 | 32.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 49 | 424 | $1,272 | $33.32 | 2.6% |
About Abbey Camara
Abbey Camara is a Family healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1568970465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abbey Camara has received a total of $174.40 in payments from pharmaceutical and medical device companies, with $13.98 received in 2023. These payments were reported across 10 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($174.40).
As a Medicare-enrolled provider, Camara has provided services to 2,538 Medicare beneficiaries, totaling 5,128 services with total Medicare billing of $78,200. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Rome, GA
- Active Since 01/14/2018
- Last Updated 04/17/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1568970465
Products in Payments
- XIFAXAN (Drug) $26.12
- INJECTAFER (Drug) $21.69
- JARDIANCE (Drug) $21.10
- MYRBETRIQ (Drug) $19.43
- DEFINITY (Drug) $18.23
- Otezla (Drug) $16.53
- EVENITY (Biological) $14.62
- VRAYLAR (Drug) $13.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Rome
Jamie Thomas, Fnp-C, FNP-C
Family — Payments: $6,460
Ashley Carlile, Np, NP
Family — Payments: $4,868
Mrs. Stephanie Sisson, Np-C, NP-C
Family — Payments: $3,807
Heidi Cannan, Fnp, FNP
Family — Payments: $3,337
Mrs. Chenoa Dickerson, Fnp-C, FNP-C
Family — Payments: $3,241
Farrah Gardner, Np, NP
Family — Payments: $2,806